Why Copilots Failed in R&D and What Comes Next
March 16, 2026
Organizations that benefit most from AI in R&D will be those that align technology with scientific reality
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
The New Blueprint for Vaccine Development
March 12, 2026
ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness
5 min read
Precision Therapies: The Last Mile
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
A Modular Route to RNA Delivery
March 11, 2026
A supramolecular delivery platform forms self-assembling nanoparticles for RNA therapeutics
1 min read
Innovation Awards 2025: Vote for Your Winner
March 11, 2026
Help us choose the most impactful drug development and manufacturing technology of 2025
1 min read
What Does Corporate Compliance Really Mean?
March 10, 2026
Corporate compliance isn’t just about avoiding fines; it’s an opportunity to shape culture, partnerships, and everyday decision-making
10 min read
Mining the Literature for Bioprocess Gains
March 10, 2026
Automated text extraction connects culture conditions, purification steps, and productivity metrics
2 min read
Accelerating Structure-based Drug Design for Complex Membrane Proteins
March 9, 2026
Nuclera and leadXpro partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets
2 min read
Engineering CAR T Cells to Resist Tumor Immune Suppression
March 9, 2026
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
2 min read
The Strategic Role of CRA AI Agents in Clinical Research
March 6, 2026
Using agentic AI to reduce clinical trial inefficiency
7 min read
Study Explores Liver Outcomes After HIV Treatment Switch
March 5, 2026
PASO DOBLE sub-analysis reports steatosis differences at 96 weeks
1 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.